Skip to main content

ICMRA

ICMRA provides a global architecture to support enhanced communication, information sharing, crisis response and address regulatory science issues.

Main navigation

10th Anniversary
COVID-19
About Us
Meetings
Strategic Initiatives
Relationships
News
Links
Contact Us

Search

Home
About Us

About Us

History
Governance and ToR
ICMRA Chair
Structure
Strategic Framework
Participating Regulatory Authorities
ICMRA Fact Sheet

Recent Content

25 March 2026
ICMRA Summit 2025 Amsterdam Meeting Report
14 January 2026
ICMRA Statement on Regulators as communicators: strengthening regulatory communication for public health
6 January 2026
Update - Real-World Evidence for Public Health Emergencies WG Meeting Summaries
23 December 2025
PQKM ICMRA-industry virtual workshop - summary report
21 November 2025
World AMR Awareness Week 2025 - Act Now: Protect our present, secure our future
29 October 2025
Appointment of new ICMRA Chair
29 October 2025
PQKM ICMRA-industry virtual workshop - materials and video recording

COVID-19

Vaccines Confidence Statement for HCPs (Revised 17 May 2022)
Remote Inspections Reflection Paper
Statement on Therapeutics
Emergency Use Approval Deep Dive Report
Report on Regulatory Flexibilities
Joint Statement on Transparency
Statement on Continuation of Vaccine Trials
Joint Statement on Regulatory Alignment
Statement on Clinical Trials
Statement on COVID-19

Strategic Initiatives

Antimicrobial Resistance (AMR)
Capacity Building
Communication
Crisis Management
Innovation
Pharmaceutical Quality Knowledge Management System (PQKMS)
Pharmacovigilance Big Data Sub-WG
Pharmacovigilance Increasing Adverse Event Reporting Sub-WG
Pharmacovigilance Vaccines Sub-WG
Real-World Evidence for Public Health Emergencies
Reliance
Supply Chain Integrity

About Us

History
Governance and ToR
ICMRA Chair
Structure
Strategic Framework
Participating Regulatory Authorities
ICMRA Fact Sheet

Others

Meetings
Relationships
News
Links
Contact Us

Disclaimer

Website designed by Swissmedic and maintained by the Pharmaceuticals and Medical Devices Agency

© 2026 ICMRA